Correlation Between Sabra Health and URANIUM ROYALTY

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sabra Health and URANIUM ROYALTY at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sabra Health and URANIUM ROYALTY into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sabra Health Care and URANIUM ROYALTY P, you can compare the effects of market volatilities on Sabra Health and URANIUM ROYALTY and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sabra Health with a short position of URANIUM ROYALTY. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sabra Health and URANIUM ROYALTY.

Diversification Opportunities for Sabra Health and URANIUM ROYALTY

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Sabra and URANIUM is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Sabra Health Care and URANIUM ROYALTY P in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on URANIUM ROYALTY P and Sabra Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sabra Health Care are associated (or correlated) with URANIUM ROYALTY. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of URANIUM ROYALTY P has no effect on the direction of Sabra Health i.e., Sabra Health and URANIUM ROYALTY go up and down completely randomly.

Pair Corralation between Sabra Health and URANIUM ROYALTY

Assuming the 90 days horizon Sabra Health Care is expected to under-perform the URANIUM ROYALTY. But the stock apears to be less risky and, when comparing its historical volatility, Sabra Health Care is 2.57 times less risky than URANIUM ROYALTY. The stock trades about -0.1 of its potential returns per unit of risk. The URANIUM ROYALTY P is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  246.00  in URANIUM ROYALTY P on September 12, 2024 and sell it today you would lose (9.00) from holding URANIUM ROYALTY P or give up 3.66% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Sabra Health Care  vs.  URANIUM ROYALTY P

 Performance 
       Timeline  
Sabra Health Care 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Sabra Health Care are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Sabra Health is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
URANIUM ROYALTY P 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in URANIUM ROYALTY P are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, URANIUM ROYALTY reported solid returns over the last few months and may actually be approaching a breakup point.

Sabra Health and URANIUM ROYALTY Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sabra Health and URANIUM ROYALTY

The main advantage of trading using opposite Sabra Health and URANIUM ROYALTY positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sabra Health position performs unexpectedly, URANIUM ROYALTY can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in URANIUM ROYALTY will offset losses from the drop in URANIUM ROYALTY's long position.
The idea behind Sabra Health Care and URANIUM ROYALTY P pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges